Seven Grand Managers »

Aeglea Biotherapeutics shares owned by Seven Grand Managers

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Seven Grand Managers from 13F filings

Historical chart of Seven Grand Managers investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Seven Grand Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Seven Grand Managers

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.3M 100k 32.76

More positions owned by Seven Grand Managers

Microsoft Corporation (MSFT)
Nasdaq Omx (NDAQ)
Medline Com Cl A (MDLN)
Sandisk Corp (SNDK)
Itt (ITT)
Metropcs Communications (TMUS)
Sofi Technologies (SOFI)
Medtronic SHS (MDT)
Coherent Corp (COHR)
Ul Solutions Class A Com Shs (ULS)
Honeywell International (HON)
Galaxy Digital Cl A (GLXY)
Legence Corp Cl A (LGN)
Karman Hldgs Common Stock (KRMN)
Restaurant Brands Intl Inc Com equity / large cap (QSR)

View all positions for Seven Grand Managers

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
VR Adviser
Capital Research and Management Company - Division 3
Commodore Capital
State Street Corporation
Driehaus Capital Management
TCG Crossover Management
Tang Capital Management
Geode Capital Management
Wellington Management Company
Braidwell

View all funds holding Aeglea Biotherapeutics